More on PHAT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+75.9% Growth)
- Ratings (9.2 Score)
- FDA

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Phathom Pharmaceuticals Inc. (NQ:PHAT)
Delayed: 11.95 +0.51 (4.46%)
Prev. Close $11.44  
Open$11.60 
52 Wk High$ 
52 Wk Low$ 
Day High$12.12 
Day Low$11.49 
P/E N/A  
EPS$ 
Volume664,144 

Friends, Peers and Foes (?): SAGE, 2RH, CPIX RDHL (more...)

Jul 20, 2026 05:53 PM Form SCHEDULE 13G/A Phathom Pharmaceuticals, Filed by: MILLENNIUM MANAGEMENT LLC
Jul 20, 2026 08:00 AM Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026
Jul 16, 2026 04:31 PM Form 4 Phathom Pharmaceuticals, For: Jul 14 Filed by: Breedlove Robert Charles
Jun 23, 2026 08:00 AM Form 8-K Phathom Pharmaceuticals, For: Jun 23
Jun 23, 2026 07:59 AM Phathom completes enrollment in Phase 2 EoE trial of Voquezna
Jun 23, 2026 07:59 AM Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
Jun 17, 2026 06:50 AM H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
May 27, 2026 04:30 PM Form 4 Phathom Pharmaceuticals, For: May 22 Filed by: Parikh Asit
May 22, 2026 08:00 AM Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
May 21, 2026 05:16 PM Form 4 Phathom Pharmaceuticals, For: May 19 Filed by: Parikh Asit
View All Articles

Entities mentioned with PHAT

View All Entities